SCHEMBL14770599

SCHEMBL14770599

c1ccc(-c2cccc(-c3ccc4oc5ccc(-c6cccc(-n7c8ccccc8c8ccccc87)n6)cc5c4c3)c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.41
PLA2G4A P47712 4/20 0.41
PLA2G10 O15496 1/20 0.41
PRKDC P78527 3/20 0.37
PGR P06401 1/20 0.36
PTPRF P10586 5/20 0.35
PTPN2 P17706 5/20 0.35
PTPN1 P18031 5/20 0.35
GAA P10253 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CASP3 P42574 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34
MAPK1 P28482 1/20 0.34
KMT2A Q03164 1/20 0.34
TBK1 Q9UHD2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20706680 0.93 CASP3 (0.38) PLA2G2APLA2G4APLA2G10PTPRFPTPN2
SCHEMBL18560744 0.92 PLA2G2A (0.38) PLA2G2APLA2G4APLA2G10PRKDCPGR
SCHEMBL24813199 0.91 PLA2G2A (0.39) PLA2G2APLA2G4APLA2G10PRKDCPGR
SCHEMBL14770611 0.91 PLA2G2A (0.36) PLA2G2APLA2G4APLA2G10PRKDCPGR
SCHEMBL16452328 0.91 PLA2G2A (0.36) PLA2G2APLA2G4APLA2G10PRKDCPGR
SCHEMBL14770691 0.91 PLA2G2A (0.36) PLA2G2APLA2G4APLA2G10PRKDCPGR
SCHEMBL12455122 0.91 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10PRKDCPGR
SCHEMBL19849260 0.90 PLA2G2A (0.37) PLA2G2APLA2G4APLA2G10PRKDCPGR
SCHEMBL16674255 0.90 PLA2G2A (0.37) PLA2G2APLA2G4APLA2G10PTPRFPTPN2
SCHEMBL18560779 0.89 PLA2G2A (0.36) PLA2G2APLA2G4APLA2G10PRKDCPTPRF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9604972-B2 Nitrogen-containing heteroaromatic ring compound IDEMITSU KOSAN CO., LTD. (JP) 2017-03-28 US disclosed
US-9604972-B2 Nitrogen-containing heteroaromatic ring compound IDEMITSU KOSAN CO., LTD. (JP) 2017-03-28 US disclosed
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2013-03-14 US disclosed
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2013-03-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND TDO2, AHR, NOC2L PLA2G2A 4744/4885PLA2G4A 4639/4885PLA2G10 4734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.